Search Results

Deals

PerkinElmer Acquires Covaris to Create an Innovation-Led, Global Life-Sciences and Diagnostics Platform

PerkinElmer today announced that it has acquired Covaris, a leading developer of solutions to empower life science innovations.

December 4, 2023

·

4 min read

Business

PerkinElmer Board Declares Quarterly Dividend - April 25, 2023

The Board of Directors of PerkinElmer, Inc. declared a regular quarterly dividend of $0.07 per share of common stock.

April 25, 2023

·

1 min read

Business

PerkinElmer to Hold Earnings Call on Thursday, May 11, 2023

PerkinElmer Inc. (NYSE: PKI), today announced that it will release its first quarter 2023 financial results prior to market open on Thursday, May 11, 2023.

April 12, 2023

·

1 min read

Business

PerkinElmer Board Declares Quarterly Dividend - Jan 26, 2023

The Board of Directors of PerkinElmer, Inc. declared a regular quarterly dividend of $0.07 per share of common stock.

January 26, 2023

·

1 min read

Genetown

PerkinElmer Launches EnVison Nexus Multimode Plate Reader to Drive Improved Research and Discovery Workflows

PerkinElmer Launches EnVison Nexus Multimode Plate Reader to Drive Improved Research and Discovery Workflows.

February 24, 2023

·

4 min read

FDA

PerkinElmer’s Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection

PerkinElmer’s Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection.

September 22, 2022

·

3 min read

Genetown

PerkinElmer to Present at Upcoming Investor Conferences - February 22, 2023

PerkinElmer Inc. , (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Cowen 43rd Annual Health Care Conference and the Barclays Global Healthcare Conference.

February 22, 2023

·

1 min read

Genetown

PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

PerkinElmer Inc. today announced that the Company will present at the virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023 at 2:15 p.m. ET.

March 9, 2023

·

1 min read

Business

Dirk Bontridder Appointed as CEO of New PerkinElmer Business Acquired by New Mountain Capital

The new PerkinElmer business acquired by New Mountain Capital announced today the appointment of Dirk Bontridder as Chief Executive Officer effective March 13, 2023.

March 20, 2023

·

3 min read

Genetown

PerkinElmer to Present at 2022 Stifel Healthcare Conference

PerkinElmer Inc. today announced that the Company will present at the 2022 Stifel Healthcare Conference on Wednesday, November 16, 2022 at 9:10 a.m. ET in New York, NY.

November 10, 2022

·

1 min read